Securities Fraud Investigation Into agilon health, inc. (AGL) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm
Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of agilon health, inc. (“agilon” or the “Company”) (
NYSE: AGL) investors concerning the Company’s possible violations of the federal securities laws.
agilon health, inc. (AGL) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
Law Offices of Howard G. Smith announces an investigation on behalf of agilon health, inc. (“agilon” or the “Company”) (
NYSE: AGL) investors concerning the Company’s possible violations of federal securities laws.
UPCOMING DEADLINE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of agilon healthFaruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In agilon health To Contact Him Directly To Discuss Their Options
Securities Fraud Investigation Into agilon health, inc. (AGL) Announced – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
The Law Offices of Frank R. Cruz announces an investigation of agilon health, inc. (“agilon” or the “Company”) (
NYSE: AGL) on behalf of investors concerning the Company’s possible violations of federal securities laws.
AGILON HEALTH, INC. (NYSE: AGL) INVESTOR ALERT Investors With Large Losses in agilon health, inc. Should Contact Bernstein Liebhard LLP To Discuss Their RightsNEW YORK, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the securities of agilon health, inc. (“Agilon” or the “Company”) (
NYSE: AGL) between February 26, 2025 and August 4, 2025, inclusive.
Agilon Healthc, Inc. Class Action Notice: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Agilon Health, Inc. Class Action LawsuitSAN DIEGO, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired agilon health, inc. (
NYSE: AGL) securities between February 26, 2025 and August 4, 2025. Agilon describes itself as the "trusted partner empowering physicians to transform health care in our communities."
2 Cash-Heavy Stocks Worth Your Attention and 1 Facing HeadwindsA surplus of cash can mean financial stability, but it can also indicate a reluctance (or inability) to invest in growth.
Some of these companies also face challenges like stagnating revenue, declining market share, or limited scalability.
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in agilon health, inc. of Class Action Lawsuit and Upcoming Deadlines - AGLNEW YORK, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against agilon health, inc. (“Agilon” or the “Company”) (
NYSE: AGL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
agilon health (AGL) Shares Skyrocket, What You Need To KnowShares of healthcare services company Agilon Health (
NYSE:AGL) jumped 14.4% in the afternoon session after Wall Street analyst price targets indicated a significant potential upside for the shares.
AGL Investors Have Opportunity to Lead agilon health, inc. Securities Fraud Lawsuit with the Schall Law FirmLOS ANGELES, Jan. 06, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against agilon health, inc. (“Agilon” or “the Company”) (
NYSE: AGL) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
AGILON ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Agilon Health, Inc. and Encourages Investors to Contact the FirmBragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Agilon (AGL) To Contact Him Directly To Discuss Their Options
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of agilon health
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against agilon health, inc. (“agilon” or the “Company”) (
NYSE: AGL) and reminds investors of the March 2, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
agilon health, inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – AGL
The DJS Law Group reminds investors of a class action lawsuit against agilon health, inc. (“Agilon” or “the Company”) (
NYSE: AGL) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
AGL Investors Have Opportunity to Lead agilon health, inc. Securities Fraud Lawsuit with the Schall Law Firm
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against agilon health, inc. (“Agilon” or “the Company”) (
NYSE: AGL) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Investor Notice: Robbins LLP Informs Investors of the Agilon Health, Inc. Securities Class Action
Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired agilon health, inc. (
NYSE: AGL) securities between February 26, 2025 and August 4, 2025. Agilon describes itself as the "trusted partner empowering physicians to transform health care in our communities."
EQUITY ALERT: Rosen Law Firm Files Securities Class Action Lawsuit on Behalf of agilon health, inc. Investors – AGL
Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of the securities of agilon health, inc. (
NYSE: AGL) between February 26, 2025 and August 4, 2025, both dates inclusive (the “Class Period”). The lawsuit seeks to recover damages for agilon investors under the federal securities laws.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of agilon health, Inc. - AGLNEW YORK, Dec. 30, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of agilon health, Inc. (“agilon” or the “Company”) (
NYSE: AGL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
1 Cash-Burning Stock with Exciting Potential and 2 Facing HeadwindsRapid spending isn’t always a sign of progress.
Some cash-burning businesses fail to convert investments into meaningful competitive advantages, leaving them vulnerable.
1 Stock Under $10 to Consider Right Now and 2 That UnderwhelmInvestors can certainly boost their returns by concentrating on stocks trading between $1 and $10.
However, a disciplined approach is necessary because many of these businesses are speculative and lack the underlying fundamentals to support their prices.
Why agilon health (AGL) Stock Is Trading Lower TodayShares of healthcare services company Agilon Health (
NYSE:AGL) fell 3.9% in the morning session after the stock's negative momentum continued as the company was dropped from the S&P Health Care Services Select Industry Index.
2 Unprofitable Stocks for Long-Term Investors and 1 We Find RiskyUnprofitable companies can burn through cash quickly, leaving investors exposed if they fail to turn things around.
Without a clear path to profitability, these businesses risk running out of capital or relying on dilutive fundraising.
